Market Cap (In INR)
52.91 Billion
Revenue (In INR)
5.71 Billion
Net Income (In INR)
707.6 Million
Avg. Volume
198.09 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 554.1-1050.15
- PE
- -
- EPS
- -
- Beta Value
- 0.441
- ISIN
- INE594H01019
- CUSIP
- Y8T01E103
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Rahul Franklin Guha
- Employee Count
- -
- Website
- https://www.thyrocare.com
- Ipo Date
- 2016-05-10
- Details
- Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
More Stocks
-
UPLUPL Limited
UPL
-
NFPDF
-
YNGN
-
ZYDUSLIFEZydus Lifesciences Limited
ZYDUSLIFE
-
TBLT
-
RPGLIFERPG Life Sciences Limited
RPGLIFE
-
GOACARBONGoa Carbon Limited
GOACARBON
-
ESSITY-AEssity AB (publ)
ESSITY-A